Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,229 signal articles · 70 in last 24h · 160,153 total before filter · latest 1h ago
70last 24h
802last 7d
119● bullish (7d)
80● bearish (7d)
214publishers
AllMacro166Earnings200M&A85Regulatory15Product13Analyst25
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Roku beats quarterly revenue estimates on advertising, subscriptions strength
Reuters55d agobullish
Roku beats quarterly revenue estimates on advertising, subscriptions strength

Streaming platform Roku on Thursday reported second-quarter revenue that beat Wall Street ‌estimates, driven by its advertising and subscriptions segments. Roku ‌is awaiting the closure of a deal to be acquired by ​Fox Corp for$22 billion, uniting the broadcaster's content empire with Roku's streaming distribution footprint. • Roku, a content distributor, carries streaming apps from Paramount and Netflix and has ⁠benefited from consumers leaving traditional TV.

Twilio (NYSE:TWLO) Delivers Strong Q2 CY2026 Numbers, Stock Jumps 15.7%
StockStory55d agobullish
Twilio (NYSE:TWLO) Delivers Strong Q2 CY2026 Numbers, Stock Jumps 15.7%

Customer engagement platform Twilio (NYSE:TWLO) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 22% year on year to $1.50 billion. On top of that, next quarter’s revenue guidance ($1.51 billion at the midpoint) was surprisingly good and 3.2% above what analysts were expecting. Its non-GAAP profit of $1.47 per share was 11.1% above analysts’ consensus estimates.

Moderna (MRNA) Wins Flu Vaccine Approval, Is It Fully Priced?
Simply Wall St.55d agobullish
Moderna (MRNA) Wins Flu Vaccine Approval, Is It Fully Priced?

Moderna (MRNA) is back in focus after the US Food and Drug Administration approved mFLUSIVA, the company’s mRNA based flu vaccine for adults aged 50 and over, sparking renewed interest in the stock. See our latest analysis for Moderna. The FDA approval of mFLUSIVA comes after a period of sharp swings in Moderna’s share price, with a 1-month share price return down 31.23% but a year to date share price return up 82.29%. At the same time, the 1-year total shareholder return of 110.61% contrasts...

Archer Aviation (ACHR) Marks Two Milestones With ZEE AI Breakthrough And Midnight Flight
Simply Wall St.55d agobullish
Archer Aviation (ACHR) Marks Two Milestones With ZEE AI Breakthrough And Midnight Flight

Archer Aviation (NYSE:ACHR) reports a breakthrough ZEE AI foundation model for real time prediction of surface aircraft trajectories, aimed at supporting safer aviation and air traffic management. The company completes a piloted city to city roundtrip using its electric Midnight air taxi under an FAA collaboration, marking a step toward potential commercial urban air mobility services. Investors watching Archer Aviation and the broader push into aerial automation may also want to review...

Atlassian (NASDAQ:TEAM) Beats Expectations in Strong Q2 CY2026, Stock Jumps 37.4%
StockStory55d agobullish
Atlassian (NASDAQ:TEAM) Beats Expectations in Strong Q2 CY2026, Stock Jumps 37.4%

Collaboration software company Atlassian (NASDAQ:TEAM) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 27.6% year on year to $1.77 billion. Guidance for next quarter’s revenue was optimistic at $1.71 billion at the midpoint, 2.8% above analysts’ estimates. Its non-GAAP profit of $1.87 per share was 24.5% above analysts’ consensus estimates.

Microsoft’s (MSFT) Record Rally Puts Alphabet (GOOGL) Rivalry Back In Focus
Insider Monkey55d agobullish
Microsoft’s (MSFT) Record Rally Puts Alphabet (GOOGL) Rivalry Back In Focus

On July 30, Microsoft Corporation (NASDAQ:MSFT) delivered the single biggest one-day gain any company has ever recorded. Shares jumped more than 15% after the company forecast stronger-than-expected cloud growth and reaffirmed heavy cash generation into its new fiscal year. The move added nearly $450 billion in market value in a single session, pushing the market […]

Cloudflare Stock Jumps After Revenue Soars Past Estimates
Barrons.com55d agobullish
Cloudflare Stock Jumps After Revenue Soars Past Estimates

Cloudflare stock was climbing Thursday night after the company reported better-than-expected second-quarter financials and third-quarter guidance as artificial intelligence boosts cybersecurity demand. Cloudflare reported second-quarter adjusted earnings of 29 cents per share on revenue of $696.1 million. Analysts surveyed by FactSet were expecting earnings of 27 cents per share on revenue of $665 million.

Investing.com55d agobullish
Roku beats second quarter estimates ahead of Fox acquisition

Investing.com -- Roku Inc (NASDAQ:ROKU) reported second quarter results that exceeded analyst expectations, with adjusted earnings per share of $1.08 compared to the consensus estimate of $0.60, and revenue of $1.35 billion versus the $1.3 billion estimate.

Airbnb Stock Jumps After Q2 Earnings Beat, Strong Travel Demand Forecast
Investor's Business Daily55d agobullish
Airbnb Stock Jumps After Q2 Earnings Beat, Strong Travel Demand Forecast

Airbnb stock leaped late Thursday after the online vacation rental platform posted second-quarter results ahead of estimates and offered a strong forecast for the September quarter. Airbnb earned $1.37 per share for the June-ended quarter, up 33% from a year earlier. The gross value of bookings on Airbnb's platform increased 16% to $27.2 billion.

Halozyme Therapeutics (NASDAQ:HALO) Beats Expectations in Strong Q2 CY2026, Guides for Strong Full-Year Sales
StockStory55d agobullish
Halozyme Therapeutics (NASDAQ:HALO) Beats Expectations in Strong Q2 CY2026, Guides for Strong Full-Year Sales

Biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 47.7% year on year to $481 million. The company’s full-year revenue guidance of $1.87 billion at the midpoint came in 5.9% above analysts’ estimates. Its non-GAAP profit of $2.28 per share was 25.5% above analysts’ consensus estimates.

Figs (NYSE:FIGS) Delivers Impressive Q2 CY2026, Stock Jumps 25.1%
StockStory55d agobullish
Figs (NYSE:FIGS) Delivers Impressive Q2 CY2026, Stock Jumps 25.1%

Healthcare apparel company Figs (NYSE:FIGS) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 28.8% year on year to $196.6 million. Its GAAP profit of $0.15 per share was significantly above analysts’ consensus estimates.

Cloudflare (NYSE:NET) Reports Bullish Q2 CY2026, Stock Jumps 14.9%
StockStory55d agobullish
Cloudflare (NYSE:NET) Reports Bullish Q2 CY2026, Stock Jumps 14.9%

Cloud security and performance company Cloudflare (NYSE:NET) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 35.9% year on year to $696.1 million. Guidance for next quarter’s revenue was optimistic at $736.5 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $0.29 per share was 7.5% above analysts’ consensus estimates.

Airbnb Raises Guidance After Second-Quarter Earnings Beat
Barrons.com56d agobullish
Airbnb Raises Guidance After Second-Quarter Earnings Beat

Vacation rental site Airbnb beat second-quarter earnings expectations and again raised its full-year outlook, crediting an accelerated pace of bookings and continued strong travel demand despite higher costs. Airbnb shares were up more than 11% in after hours trading, after closing down 0.6% at $151.64 in regular trading. Airbnb said it delivered some of the strongest results in years during the first half of 2026, and that it exceeded its outlook across every key metric for the second quarter.

Block (XYZ) Stock May Be 14% Undervalued On Q2 Earnings Beat
Simply Wall St.56d agobullish
Block (XYZ) Stock May Be 14% Undervalued On Q2 Earnings Beat

Block stock has delivered a steep 68.9% decline over the past five years, yet the current checks send mixed messages on value, with the Excess Returns intrinsic value estimate suggesting upside while earnings based multiples lean expensive. The share price performance over five years is down 68.9%, which puts a spotlight on whether the current level reflects a reset opportunity or lingering concerns. Recent growth in Cash App and Square activity can support higher earnings expectations,...